Qing Jiang

US Patent:

7399784, Jul 15, 2008

Filed:

Nov 26, 2002

Appl. No.:

10/304918

Inventors:

Bruce N. Ames - Berkeley CA, US
Qing Jiang - Berkeley CA, US

Assignee:

Children's Hospital & Research Center at Oakland - Oakland CA

International Classification:

A61K 31/56
A61K 31/34
A61K 31/35

US Classification:

514474, 514171, 514458, 514456, 424 59

Abstract:

Anti-obesity compositions include medicaments comprising predetermined amounts of a phytyl substituted chromanol and an obesity-promoting drug, wherein: said medicament is in unit dosage form suitable for pharmaceutical administration; said phytyl substituted chromanol is a gamma-tocopherol, delta-tocopherol, alpha-tocotrienol, gamma-tocotrienol or delta-tocotrienol; said obesity-promoting drug is a corticosteroid or an anti-diabetes drug such as a hypoglycemic drug, starch blocker, glucose production blocker or insulin sensitizer.

US Patent:

7964587, Jun 21, 2011

Filed:

Jun 22, 2005

Appl. No.:

11/159917

Inventors:

Bruce N. Ames - Berkeley CA, US
Qing Jiang - Berkeley CA, US

Assignee:

Children's Hospital & Research Center at Oakland - Oakland CA

International Classification:

A61K 31/355
A01N 43/16

US Classification:

514183, 514458

Abstract:

Anti-inflammatory compositions include medicaments comprising predetermined amounts of a phytyl substituted chromanol and a prostaglandin Einhibitor, wherein: said medicament is in unit dosage form suitable for pharmaceutical administration; said phytyl substituted chromanol is a gamma-tocopherol, delta-tocopherol, gamma-tocotrienol or delta-tocotrienol; said PGEinhibitor is a non-steroidal anti-inflammatory drug or an omega-3 fatty acid, such as docosahexaenoic acid and eicosapentaenoic acid.

US Patent:

20040102421, May 27, 2004

Filed:

Nov 21, 2002

Appl. No.:

10/301211

Inventors:

Bruce Ames - Berkeley CA, US
Qing Jiang - Berkeley CA, US

Assignee:

Children's Hospital Research Center at Oakland

International Classification:

A61K031/60
A61K031/415
A61K031/355
A61K031/192

US Classification:

514/165000, 514/406000, 514/458000, 514/570000, 514/560000

Abstract:

Anti-inflammatory compositions include medicaments comprising predetermined amounts of a phytyl substituted chromanol and a prostaglandin Einhibitor, wherein: said medicament is in unit dosage form suitable for pharmaceutical administration; said phytyl substituted chromanol is a gamma-tocopherol, delta-tocopherol, gamma-tocotrienol or delya-tocotrienol; said PGEinhibitor is a non-steroidal anti-inflammatory drug or an omega-3 fatty acid, such as docosahexaenoic acid and eicosapentaenoic acid.

US Patent:

20040246563, Dec 9, 2004

Filed:

Jun 4, 2003

Appl. No.:

10/455151

Inventors:

Raymond Chu - Cupertino CA, US
Qing Jiang - San Jose CA, US

Assignee:

ACCEEZE, Inc.

International Classification:

G02F001/33

US Classification:

359/308000

Abstract:

This invention includes an Acousto-optical tuning device by employing the TeO2 in share mode, non-collinear and in high RF frequency (or large Bragg's deflection region), it is able to achieve the telecomm worthy tunable filter that provides high tuning speed, no-moving parts, very narrow filter line-width (0.2 nm for instance) and with miniature size practical for a optical telecom active module. This tuning characteristic is achieved by taking the particular advantages that the angle of incidence (AOI) and angle of diffraction (AOD) are divergent in a frequency range just suitable for a shorter wavelength application required by modern telecommunication systems while the acoustic wave decay in this frequency range can be properly managed to achieve the design goals. Furthermore, by generating a diffracted beam with larger AOD, implementation of filtering for optical propagations of different wavelengths can be conveniently selected. Other than the TeO2 crystals, the AOTF can also be formed with AsS3 and GeAsSe crystals based on the same acoustic-optical interaction processes at a higher RF frequency range as discussed in the above descriptions.

US Patent:

20110207808, Aug 25, 2011

Filed:

Sep 17, 2009

Appl. No.:

13/119737

Inventors:

Qing Jiang - West Lafayette IN, US
Richard Anthony Gibbs - West Lafayette IN, US
Markus A. Lill - West Lafayette IN, US

Assignee:

PURDUE RESEARCH FOUNDATION - West Lafayette IN

International Classification:

A61K 31/352
A61K 31/36
A61P 29/00
A61P 35/00
A61P 9/00
A61P 25/28

US Classification:

514456

Abstract:

Provided are long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds.

US Patent:

20170296505, Oct 19, 2017

Filed:

Jun 8, 2017

Appl. No.:

15/617432

Inventors:

- West Lafayette IN, US
Qing Jiang - West Lafayette IN, US

Assignee:

Purdue Research Foundation - West Lafayette IN

International Classification:

A61K 31/353
A61K 45/06

Abstract:

Long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds are provided herein.

US Patent:

20150073044, Mar 12, 2015

Filed:

Aug 29, 2014

Appl. No.:

14/472799

Inventors:

- West Lafayette IN, US
QING JIANG - WEST LAFAYETTE IN, US

International Classification:

C07D 311/72
A61K 31/353
A61K 31/343
A61K 31/12

US Classification:

514456, 549407

Abstract:

Long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds are provided herein.